Owens & Minor, Inc. (NYSE:OMI) shares hit a new 52-week low during trading on Wednesday after Zacks Investment Research downgraded the stock from a hold rating to a sell rating. The company traded as low as $3.87 and last traded at $3.87, with a volume of 53703 shares trading hands. The stock had previously closed at $4.02.
A number of other research analysts have also recently commented on OMI. Leerink Swann set a $9.00 price target on Owens & Minor and gave the company a “hold” rating in a research report on Wednesday, October 31st. Bank of America dropped their price target on Owens & Minor from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Thursday, January 3rd. Barclays reaffirmed an “underweight” rating and set a $8.00 price target (down previously from $12.00) on shares of Owens & Minor in a research report on Thursday, November 1st. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $8.50 price objective on shares of Owens & Minor in a research note on Friday, November 2nd. Two equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. Owens & Minor presently has a consensus rating of “Hold” and an average price target of $6.70.
Several large investors have recently added to or reduced their stakes in the stock. Cardinal Capital Management bought a new stake in shares of Owens & Minor during the 1st quarter valued at $277,000. Geode Capital Management LLC raised its stake in shares of Owens & Minor by 12.4% during the 4th quarter. Geode Capital Management LLC now owns 660,313 shares of the company’s stock valued at $4,179,000 after purchasing an additional 72,726 shares during the period. Norges Bank bought a new stake in shares of Owens & Minor during the 4th quarter valued at $6,208,000. Dimensional Fund Advisors LP raised its stake in shares of Owens & Minor by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,997,973 shares of the company’s stock valued at $31,637,000 after purchasing an additional 19,174 shares during the period. Finally, FMR LLC raised its stake in shares of Owens & Minor by 159,300.0% during the 4th quarter. FMR LLC now owns 4,782 shares of the company’s stock valued at $30,000 after purchasing an additional 4,779 shares during the period. Institutional investors own 95.33% of the company’s stock.
Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Tuesday, February 19th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.05). Owens & Minor had a negative net margin of 4.44% and a positive return on equity of 8.99%. The company had revenue of $2.54 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the previous year, the firm posted $0.38 earnings per share. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities analysts expect that Owens & Minor, Inc. will post 0.64 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were paid a $0.0025 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $0.01 dividend on an annualized basis and a yield of 0.26%. Owens & Minor’s dividend payout ratio is currently 0.87%.
COPYRIGHT VIOLATION NOTICE: “Owens & Minor (OMI) Reaches New 12-Month Low Following Analyst Downgrade” was reported by WKRB News and is owned by of WKRB News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.wkrb13.com/2019/04/12/owens-minor-omi-reaches-new-12-month-low-following-analyst-downgrade.html.
Owens & Minor Company Profile (NYSE:OMI)
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.
Recommended Story: Should You Consider an Index Fund?
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.